MyProstateScore 2.0 (MPS2) offers physicians and patients the most comprehensive and flexible prostate cancer risk assessment tool. I am a Provider I am a Patient MYPROSTATESCORE 2.0 Clear Results. Confident Decision. MPS2 is a urine test designed to predict the presence of clinically significant...
Prostate cancer risk assessment tools in an unscreened population. World J Urol, 1, 6.Lundon DJ, Kelly BD, Foley R, Loeb S, Fitzpatrick JM, Watson RW, et al. Prostate cancer risk assessment tools in an unscreened population. World J Urol 2015;33:827‑32....
Risk of high-grade cancer on a prostate biopsy nomogramis used to estimate the likelihood of having high-grade prostate cancer in people who have been considered eligible for prostate biopsy by a urologist. This tool does not apply to those who have already been diagnosed with prostate cancer....
Prostate cancer risk assessmentPCPT risk calculatorAge and race-specific reference rangesWhile the current value of prostate cancer screening in reducing mortality is debatable, there is no doubt that screening has created overdetection of clinically insignificant cancers. An......
Prostate cancer is a heterogeneous cancer with widely varying levels of morbidity and mortality. Approaches to prostate cancer screening, diagnosis, surveillance, treatment and management differ around the world. To identify the highest priority research
To evaluate the validity of the cancer of the prostate risk assessment (CAPRA) score, a newly developed nomogram for preoperative prediction of recurrence after radical prostatectomy, in a single institution in Korea. We retrospectively studied 115 men who had undergone radical prostatectomy as the fi...
Medications and other factors can skew a PSA test and impact your prostate cancer risk assessment. Here's what to avoid before a PSA test.
Objective To perform a systematic review of data guiding the assessment of elderly prostate cancer patients that addresses the risk from cancer and treatment, and to discuss a patient-centered approach to incorporating these factors into decision making. Evidence acquisition Evidence was gathered via a...
Development of a decision-making tool to predict risk of prostate cancer: The cancer of the prostate risk index (CAPRI) test Development of a decision-making tool to predict risk of prostate can- cer: the Cancer of the Prostate Risk Index (CAPRI) test. Urology 1997; 50: ... Scott A. ...
Genetic and environmental variables play a role in determining prostate cancer risk. This article highlights the latest evidence regarding the risk factors for prostate cancer. The current screening strategies using prostate-specific antigen and digital rectal examination are also discussed, as well as ...